Does Lacosamide Affect Blood Pressure?
Lacosamide, sold as Vimpat, is an anticonvulsant for partial-onset seizures and primary generalized tonic-clonic seizures. It does not treat high blood pressure (hypertension) and lacks FDA approval for cardiovascular use. Clinical trials and post-marketing data show no direct causal link to worsening hypertension, but it can influence blood pressure in some patients.[1][2]
Common Cardiovascular Side Effects
Lacosamide may cause:
- Atrial fibrillation or flutter (1-10% incidence, higher in elderly or heart disease patients).
- Dose-dependent PR interval prolongation on ECG, risking conduction delays.
- Occasional hypotension or hypertension reports (less than 1%), typically transient.[1][3]
Hypertension is not a frequent adverse event; one analysis of over 30,000 patients found blood pressure changes in under 2%, unrelated to baseline hypertension.[2]
Is It Safe with Existing High Blood Pressure?
Patients with hypertension can use lacosamide if monitored, but caution applies:
- Risk of arrhythmias increases with uncontrolled hypertension or heart conditions—ECG recommended before and during treatment.
- No specific contraindication for hypertension alone, per prescribing information.
- Animal studies showed no hypertensive effects; human data aligns.[1][4]
Consult a doctor for individual risks, especially if on antihypertensives—no known major interactions with common blood pressure meds like ACE inhibitors or beta-blockers.[3]
What Do Patients with Hypertension Report?
Real-world forums and FDA adverse event reports note rare blood pressure spikes post-lacosamide initiation, often tied to IV administration or rapid dosing. Most resolve without intervention. No evidence of long-term hypertension induction.[5]
Monitoring and Precautions